Insider Trading Alert - JAZZ, URI And JJSF Traded By Insiders

Yesterday, Feb. 17, 2016, 75 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $235.30 to $7,252,323.17.

Highlighted Stocks Traded by Insiders:

Jazz Pharmaceuticals (JAZZ) - FREE Research Report

Miller Michael Patrick, who is SVP, US Commercial at Jazz Pharmaceuticals, sold 100 shares at $115.63 on Feb. 17, 2016. Following this transaction, the SVP, US Commercial owned 13,461 shares meaning that the stake was reduced by 0.74% with the 100-share transaction.

The shares most recently traded at $123.04, up $7.41, or 6.02% since the insider transaction. Historical insider transactions for Jazz Pharmaceuticals go as follows:

  • 4-Week # shares sold: 2,500
  • 12-Week # shares sold: 8,124
  • 24-Week # shares sold: 48,713

The average volume for Jazz Pharmaceuticals has been 602,900 shares per day over the past 30 days. Jazz Pharmaceuticals has a market cap of $7.3 billion and is part of the health care sector and drugs industry. Shares are down 12.64% year-to-date as of the close of trading on Wednesday.

Jazz Pharmaceuticals Public Limited Company, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various medical needs in the United States, Europe, and internationally. The company has a P/E ratio of 22.8. Currently, there are 10 analysts who rate Jazz Pharmaceuticals a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JAZZ - FREE

TheStreet Quant Ratings rates Jazz Pharmaceuticals as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, notable return on equity, reasonable valuation levels and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Jazz Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

United Rentals (URI) - FREE Research Report

Alvarez Jose B, who is Director at United Rentals, bought 1,190 shares at $47.42 on Feb. 17, 2016. Following this transaction, the Director owned 20,822 shares meaning that the stake was boosted by 6.06% with the 1,190-share transaction.

The shares most recently traded at $48.36, up $0.94, or 1.93% since the insider transaction. Historical insider transactions for United Rentals go as follows:

  • 4-Week # shares bought: 7,700
  • 4-Week # shares sold: 15,894
  • 12-Week # shares bought: 7,700
  • 12-Week # shares sold: 32,894
  • 24-Week # shares bought: 7,700
  • 24-Week # shares sold: 63,597

The average volume for United Rentals has been 2.4 million shares per day over the past 30 days. United Rentals has a market cap of $4.3 billion and is part of the services sector and diversified services industry. Shares are down 33.58% year-to-date as of the close of trading on Wednesday.

United Rentals, Inc., through its subsidiaries, operates as an equipment rental company. It operates in two segments, General Rentals; and Trench, Power, and Pump. The company has a P/E ratio of 7.8. Currently, there are 7 analysts who rate United Rentals a buy, 1 analyst rates it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on URI - FREE

TheStreet Quant Ratings rates United Rentals as a hold. The company's strengths can be seen in multiple areas, such as its notable return on equity, attractive valuation levels and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, generally higher debt management risk and a generally disappointing performance in the stock itself. Get the full United Rentals Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

J&J Snack Foods (JJSF) - FREE Research Report

Moore Dennis G, who is Sr. Vice President at J&J Snack Foods, bought 49 shares at $112.09 on Feb. 17, 2016. Following this transaction, the Sr. Vice President owned 75,501 shares meaning that the stake was boosted by 0.06% with the 49-share transaction.

Pape Robert Joseph, who is Senior Vice President at J&J Snack Foods, bought 36 shares at $91.78 on Feb. 17, 2016. Following this transaction, the Senior Vice President owned 12,186 shares meaning that the stake was boosted by 0.3% with the 36-share transaction.

Law Gerard Garfield, who is Senior Vice President at J&J Snack Foods, bought 527 shares at $86.65 on Feb. 17, 2016. Following this transaction, the Senior Vice President owned 8,861 shares meaning that the stake was boosted by 6.32% with the 527-share transaction.

The shares most recently traded at $108.28, up $21.63, or 19.98% since the insider transaction. Historical insider transactions for J&J Snack Foods go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 6,238
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 6,238
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 6,238

The average volume for J&J Snack Foods has been 69,900 shares per day over the past 30 days. J&J Snack Foods has a market cap of $2.0 billion and is part of the consumer goods sector and food & beverage industry. Shares are down 7.58% year-to-date as of the close of trading on Wednesday.

J&J Snack Foods Corp. manufactures, markets, and distributes various nutritional snack foods and beverages to the food service and retail supermarket industries in the United States, Mexico, and Canada. The stock currently has a dividend yield of 1.44%. The company has a P/E ratio of 28.4. Currently, there is 1 analyst who rates J&J Snack Foods a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on JJSF - FREE

TheStreet Quant Ratings rates J&J Snack Foods as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, solid stock price performance and growth in earnings per share. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full J&J Snack Foods Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Video: What to Expect From Microsoft's Earnings Thursday

Video: What to Expect From Microsoft's Earnings Thursday

Top Strategist Reveals the Stocks to Focus On For the Last Half of 2018

Top Strategist Reveals the Stocks to Focus On For the Last Half of 2018

How to Play Splunk as Cloud Names Soar

How to Play Splunk as Cloud Names Soar

Rewind: Jim Cramer Says the Cloud Kings Will Be the New FAANG

Rewind: Jim Cramer Says the Cloud Kings Will Be the New FAANG

Danaher Shares Surge After Dental Spinoff Plan, Solid Q2 Earnings

Danaher Shares Surge After Dental Spinoff Plan, Solid Q2 Earnings